Maegim한국어

전진바이오팜

110020KOSDAQSector: Chemicals & Materials
₩1,850 2.55%Market cap ₩16.8BAs of Jul 21, 2026 close · updated once daily
C
Grade C47.1 ptsTop 59% of 2,523 stocks
Financial strength
60.5
Growth momentum
47.1
Price attractiveness
31.7

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

1

Financial strength

60.5
How much debt does it carry relative to equity?
Debt-to-equity ratio
6.3%
Above median · Top 2.1% in sector
Sector median 65.0%
Can it cover what's due within a year?
Current ratio
1083.1%
Above median · Top 4% in sector
Sector median 154.0%
How much of revenue becomes profit?
Operating margin
-2.5%
Below median · Top 78.2% in sector
Sector median 3.8%
How much did it earn on its own capital?
ROE (return on equity)
-1.1%
Below median · Top 73.7% in sector
Sector median 3.6%

Source filing: annual report (separate) — view original

2

Growth momentum

47.1
How much did revenue grow in a year?
Revenue growth (YoY)
-28.9%
Below median · Top 95.5% in sector
Sector median 0.3%
Has it grown steadily over three years?
Revenue 3-year CAGR
20.7%
Above median · Top 3.3% in sector
Sector median -1.5%
Did core profits grow in a year?
Operating income change (YoY)
-129.6%
Below median · Top 90.7% in sector
Sector median -6.6%
Are core profits higher than three years ago?
Operating income change (3Y)
89.2%
Above median · Top 22.2% in sector
Sector median -12.4%

Source filing: annual report (separate) — view original

3

Price attractiveness

31.7
Is the price expensive relative to earnings?
P/E (price-to-earnings)
Loss-making (P/E not computable)
Below median · Top 73.3% in sector
Sector median P/E of profitable peers 13.5x · 28% loss-making
Is the price expensive relative to book value?
P/B (price-to-book)
0.96x
Below median · Top 63.4% in sector
Sector median 0.69x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 266 stocks in Chemicals & Materials

S2A51B86C46D59F20